According to the research report published by Market IntelliX, the global market for Human Pain Management Drug should grow from US$ 72000 million in 2022 to US$ 96030 million by 2029, with a CAGR of 4.2% for the period of 2023-2029.

China Human Pain Management Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Human Pain Management Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, OTC segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Human Pain Management Drug include AbbVie Inc. (Allergan plc), Bristol Myers Squibb Co., Sanofi S.A., Boehringer Ingelheim International GmbH, Pfizer Inc., Zydus Lifesciences Ltd. (Cadila Pharmaceuticals), GSK plc., Abbott Laboratories, Inc. and Novartis AG, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Pain relievers, including acetaminophen, NSAIDs and opioids, can ease temporary aches and chronic pain.

This report aims to provide a comprehensive study of the global market for Human Pain Management Drug. Report Highlights:

(1) Global Human Pain Management Drug market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Human Pain Management Drug market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Human Pain Management Drug market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Human Pain Management Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Human Pain Management Drug segment by type and by application and regional segment by type and by application.

(6) Human Pain Management Drug industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

OTC

Rx

Market segment by application, can be divided into

Hospital

Retail Pharmacy

Other

Market segment by players, this report covers

AbbVie Inc. (Allergan plc)

Bristol Myers Squibb Co.

Sanofi S.A.

Boehringer Ingelheim International GmbH

Pfizer Inc.

Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)

GSK plc.

Abbott Laboratories, Inc.

Novartis AG

Johnson & Johnson (Janssen Pharmaceuticals, Inc.)

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceuticals Ltd.

Mallinckrodt Pharmaceuticals

Endo Pharmaceuticals Inc.

Bayer AG

F. Hoffmann-La Roche Ltd.

Procter & Gamble

AstraZeneca

Cardinal Health

Perrigo Company Plc.

Bausch Health Companies Inc.

Viatris

Amneal Pharmaceuticals

Purdue Pharmaceuticals L.P.

1 Market Overview

1.1 Product Overview and Scope of Human Pain Management Drug

1.2 Global Human Pain Management Drug Market Size and Forecast

1.3 China Human Pain Management Drug Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Human Pain Management Drug Share in Global Market, 2018-2029

1.4.2 Human Pain Management Drug Market Size: China VS Global, 2018-2029

1.5 Human Pain Management Drug Market Dynamics

1.5.1 Human Pain Management Drug Market Drivers

1.5.2 Human Pain Management Drug Market Restraints

1.5.3 Human Pain Management Drug Industry Trends

1.5.4 Human Pain Management Drug Industry Policy

2 Global Competitive Situation by Company

2.1 Global Human Pain Management Drug Revenue by Company (2018-2023)

2.2 Global Human Pain Management Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Human Pain Management Drug Concentration Ratio

2.4 Global Human Pain Management Drug Mergers & Acquisitions, Expansion Plans

2.5 Global Human Pain Management Drug Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Human Pain Management Drug Revenue by Company (2018-2023)

3.2 China Human Pain Management Drug Human Pain Management Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Human Pain Management Drug, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Human Pain Management Drug Industry Chain

4.2 Human Pain Management Drug Upstream Analysis

4.3 Human Pain Management Drug Midstream Analysis

4.4 Human Pain Management Drug Downstream Analysis

5 Sights by Type

5.1 Human Pain Management Drug Classification

5.1.1 OTC

5.1.2 Rx

5.2 By Type, Global Human Pain Management Drug Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Human Pain Management Drug Revenue, 2018-2029

6 Sights by Application

6.1 Human Pain Management Drug Segment by Application

6.1.1 Hospital

6.1.2 Retail Pharmacy

6.1.3 Other

6.2 By Application, Global Human Pain Management Drug Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Human Pain Management Drug Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Human Pain Management Drug Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Human Pain Management Drug Market Size, 2018-2029

7.3 North America

7.3.1 North America Human Pain Management Drug Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Human Pain Management Drug Market Size Market Share

7.4 Europe

7.4.1 Europe Human Pain Management Drug Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Human Pain Management Drug Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Human Pain Management Drug Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Human Pain Management Drug Market Size Market Share

7.6 South America

7.6.1 South America Human Pain Management Drug Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Human Pain Management Drug Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Human Pain Management Drug Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Human Pain Management Drug Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Human Pain Management Drug Market Size, 2018-2029

8.3.2 By Company, U.S. Human Pain Management Drug Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Human Pain Management Drug Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Human Pain Management Drug Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Human Pain Management Drug Market Size, 2018-2029

8.4.2 By Company, Europe Human Pain Management Drug Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Human Pain Management Drug Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Human Pain Management Drug Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Human Pain Management Drug Market Size, 2018-2029

8.5.2 By Company, China Human Pain Management Drug Revenue Market Share, 2018-2023

8.5.3 By Type, China Human Pain Management Drug Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Human Pain Management Drug Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Human Pain Management Drug Market Size, 2018-2029

8.6.2 By Company, Japan Human Pain Management Drug Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Human Pain Management Drug Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Human Pain Management Drug Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Human Pain Management Drug Market Size, 2018-2029

8.7.2 By Company, South Korea Human Pain Management Drug Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Human Pain Management Drug Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Human Pain Management Drug Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Human Pain Management Drug Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Human Pain Management Drug Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Human Pain Management Drug Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Human Pain Management Drug Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Human Pain Management Drug Market Size, 2018-2029

8.9.2 By Company, India Human Pain Management Drug Revenue Market Share, 2018-2023

8.9.3 By Type, India Human Pain Management Drug Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Human Pain Management Drug Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Human Pain Management Drug Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Human Pain Management Drug Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Human Pain Management Drug Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Human Pain Management Drug Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 AbbVie Inc. (Allergan plc)

9.1.1 AbbVie Inc. (Allergan plc) Company Information, Head Office, Market Area and Industry Position

9.1.2 AbbVie Inc. (Allergan plc) Company Profile and Main Business

9.1.3 AbbVie Inc. (Allergan plc) Human Pain Management Drug Models, Specifications and Application

9.1.4 AbbVie Inc. (Allergan plc) Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.1.5 AbbVie Inc. (Allergan plc) Recent Developments

9.2 Bristol Myers Squibb Co.

9.2.1 Bristol Myers Squibb Co. Company Information, Head Office, Market Area and Industry Position

9.2.2 Bristol Myers Squibb Co. Company Profile and Main Business

9.2.3 Bristol Myers Squibb Co. Human Pain Management Drug Models, Specifications and Application

9.2.4 Bristol Myers Squibb Co. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.2.5 Bristol Myers Squibb Co. Recent Developments

9.3 Sanofi S.A.

9.3.1 Sanofi S.A. Company Information, Head Office, Market Area and Industry Position

9.3.2 Sanofi S.A. Company Profile and Main Business

9.3.3 Sanofi S.A. Human Pain Management Drug Models, Specifications and Application

9.3.4 Sanofi S.A. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.3.5 Sanofi S.A. Recent Developments

9.4 Boehringer Ingelheim International GmbH

9.4.1 Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position

9.4.2 Boehringer Ingelheim International GmbH Company Profile and Main Business

9.4.3 Boehringer Ingelheim International GmbH Human Pain Management Drug Models, Specifications and Application

9.4.4 Boehringer Ingelheim International GmbH Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.4.5 Boehringer Ingelheim International GmbH Recent Developments

9.5 Pfizer Inc.

9.5.1 Pfizer Inc. Company Information, Head Office, Market Area and Industry Position

9.5.2 Pfizer Inc. Company Profile and Main Business

9.5.3 Pfizer Inc. Human Pain Management Drug Models, Specifications and Application

9.5.4 Pfizer Inc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.5.5 Pfizer Inc. Recent Developments

9.6 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)

9.6.1 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Information, Head Office, Market Area and Industry Position

9.6.2 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Profile and Main Business

9.6.3 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Models, Specifications and Application

9.6.4 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.6.5 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Developments

9.7 GSK plc.

9.7.1 GSK plc. Company Information, Head Office, Market Area and Industry Position

9.7.2 GSK plc. Company Profile and Main Business

9.7.3 GSK plc. Human Pain Management Drug Models, Specifications and Application

9.7.4 GSK plc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.7.5 GSK plc. Recent Developments

9.8 Abbott Laboratories, Inc.

9.8.1 Abbott Laboratories, Inc. Company Information, Head Office, Market Area and Industry Position

9.8.2 Abbott Laboratories, Inc. Company Profile and Main Business

9.8.3 Abbott Laboratories, Inc. Human Pain Management Drug Models, Specifications and Application

9.8.4 Abbott Laboratories, Inc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.8.5 Abbott Laboratories, Inc. Recent Developments

9.9 Novartis AG

9.9.1 Novartis AG Company Information, Head Office, Market Area and Industry Position

9.9.2 Novartis AG Company Profile and Main Business

9.9.3 Novartis AG Human Pain Management Drug Models, Specifications and Application

9.9.4 Novartis AG Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.9.5 Novartis AG Recent Developments

9.10 Johnson & Johnson (Janssen Pharmaceuticals, Inc.)

9.10.1 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Information, Head Office, Market Area and Industry Position

9.10.2 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Profile and Main Business

9.10.3 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Models, Specifications and Application

9.10.4 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.10.5 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Developments

9.11 Sun Pharmaceutical Industries Ltd.

9.11.1 Sun Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position

9.11.2 Sun Pharmaceutical Industries Ltd. Company Profile and Main Business

9.11.3 Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Models, Specifications and Application

9.11.4 Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.11.5 Sun Pharmaceutical Industries Ltd. Recent Developments

9.12 Teva Pharmaceuticals Ltd.

9.12.1 Teva Pharmaceuticals Ltd. Company Information, Head Office, Market Area and Industry Position

9.12.2 Teva Pharmaceuticals Ltd. Company Profile and Main Business

9.12.3 Teva Pharmaceuticals Ltd. Human Pain Management Drug Models, Specifications and Application

9.12.4 Teva Pharmaceuticals Ltd. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.12.5 Teva Pharmaceuticals Ltd. Recent Developments

9.13 Mallinckrodt Pharmaceuticals

9.13.1 Mallinckrodt Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

9.13.2 Mallinckrodt Pharmaceuticals Company Profile and Main Business

9.13.3 Mallinckrodt Pharmaceuticals Human Pain Management Drug Models, Specifications and Application

9.13.4 Mallinckrodt Pharmaceuticals Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.13.5 Mallinckrodt Pharmaceuticals Recent Developments

9.14 Endo Pharmaceuticals Inc.

9.14.1 Endo Pharmaceuticals Inc. Company Information, Head Office, Market Area and Industry Position

9.14.2 Endo Pharmaceuticals Inc. Company Profile and Main Business

9.14.3 Endo Pharmaceuticals Inc. Human Pain Management Drug Models, Specifications and Application

9.14.4 Endo Pharmaceuticals Inc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.14.5 Endo Pharmaceuticals Inc. Recent Developments

9.15 Bayer AG

9.15.1 Bayer AG Company Information, Head Office, Market Area and Industry Position

9.15.2 Bayer AG Company Profile and Main Business

9.15.3 Bayer AG Human Pain Management Drug Models, Specifications and Application

9.15.4 Bayer AG Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.15.5 Bayer AG Recent Developments

9.16 F. Hoffmann-La Roche Ltd.

9.16.1 F. Hoffmann-La Roche Ltd. Company Information, Head Office, Market Area and Industry Position

9.16.2 F. Hoffmann-La Roche Ltd. Company Profile and Main Business

9.16.3 F. Hoffmann-La Roche Ltd. Human Pain Management Drug Models, Specifications and Application

9.16.4 F. Hoffmann-La Roche Ltd. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.16.5 F. Hoffmann-La Roche Ltd. Recent Developments

9.17 Procter & Gamble

9.17.1 Procter & Gamble Company Information, Head Office, Market Area and Industry Position

9.17.2 Procter & Gamble Company Profile and Main Business

9.17.3 Procter & Gamble Human Pain Management Drug Models, Specifications and Application

9.17.4 Procter & Gamble Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.17.5 Procter & Gamble Recent Developments

9.18 AstraZeneca

9.18.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position

9.18.2 AstraZeneca Company Profile and Main Business

9.18.3 AstraZeneca Human Pain Management Drug Models, Specifications and Application

9.18.4 AstraZeneca Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.18.5 AstraZeneca Recent Developments

9.19 Cardinal Health

9.19.1 Cardinal Health Company Information, Head Office, Market Area and Industry Position

9.19.2 Cardinal Health Company Profile and Main Business

9.19.3 Cardinal Health Human Pain Management Drug Models, Specifications and Application

9.19.4 Cardinal Health Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.19.5 Cardinal Health Recent Developments

9.20 Perrigo Company Plc.

9.20.1 Perrigo Company Plc. Company Information, Head Office, Market Area and Industry Position

9.20.2 Perrigo Company Plc. Company Profile and Main Business

9.20.3 Perrigo Company Plc. Human Pain Management Drug Models, Specifications and Application

9.20.4 Perrigo Company Plc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.20.5 Perrigo Company Plc. Recent Developments

9.21 Bausch Health Companies Inc.

9.21.1 Bausch Health Companies Inc. Company Information, Head Office, Market Area and Industry Position

9.21.2 Bausch Health Companies Inc. Company Profile and Main Business

9.21.3 Bausch Health Companies Inc. Human Pain Management Drug Models, Specifications and Application

9.21.4 Bausch Health Companies Inc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.21.5 Bausch Health Companies Inc. Recent Developments

9.22 Viatris

9.22.1 Viatris Company Information, Head Office, Market Area and Industry Position

9.22.2 Viatris Company Profile and Main Business

9.22.3 Viatris Human Pain Management Drug Models, Specifications and Application

9.22.4 Viatris Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.22.5 Viatris Recent Developments

9.23 Amneal Pharmaceuticals

9.23.1 Amneal Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

9.23.2 Amneal Pharmaceuticals Company Profile and Main Business

9.23.3 Amneal Pharmaceuticals Human Pain Management Drug Models, Specifications and Application

9.23.4 Amneal Pharmaceuticals Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.23.5 Amneal Pharmaceuticals Recent Developments

9.24 Purdue Pharmaceuticals L.P.

9.24.1 Purdue Pharmaceuticals L.P. Company Information, Head Office, Market Area and Industry Position

9.24.2 Purdue Pharmaceuticals L.P. Company Profile and Main Business

9.24.3 Purdue Pharmaceuticals L.P. Human Pain Management Drug Models, Specifications and Application

9.24.4 Purdue Pharmaceuticals L.P. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

9.24.5 Purdue Pharmaceuticals L.P. Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Human Pain Management Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Human Pain Management Drug Market Restraints

Table 3. Human Pain Management Drug Market Trends

Table 4. Human Pain Management Drug Industry Policy

Table 5. Global Human Pain Management Drug Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Human Pain Management Drug Revenue Market Share by Company (2018-2023)

Table 7. Global Human Pain Management Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Human Pain Management Drug Mergers & Acquisitions, Expansion Plans

Table 9. Global Human Pain Management Drug Manufacturers Product Type

Table 10. China Human Pain Management Drug Revenue by Company (2018-2023) & (US$ million)

Table 11. China Human Pain Management Drug Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Human Pain Management Drug Upstream (Raw Materials)

Table 13. Global Human Pain Management Drug Typical Customers

Table 14. Human Pain Management Drug Typical Distributors

Table 15. By Type, Global Human Pain Management Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Human Pain Management Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Human Pain Management Drug Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Human Pain Management Drug Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Human Pain Management Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Human Pain Management Drug Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Human Pain Management Drug Revenue Market Share, 2018-2029

Table 22. AbbVie Inc. (Allergan plc) Company Information, Head Office, Market Area and Industry Position

Table 23. AbbVie Inc. (Allergan plc) Company Profile and Main Business

Table 24. AbbVie Inc. (Allergan plc) Human Pain Management Drug Models, Specifications and Application

Table 25. AbbVie Inc. (Allergan plc) Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 26. AbbVie Inc. (Allergan plc) Recent Developments

Table 27. Bristol Myers Squibb Co. Company Information, Head Office, Market Area and Industry Position

Table 28. Bristol Myers Squibb Co. Company Profile and Main Business

Table 29. Bristol Myers Squibb Co. Human Pain Management Drug Models, Specifications and Application

Table 30. Bristol Myers Squibb Co. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 31. Bristol Myers Squibb Co. Recent Developments

Table 32. Sanofi S.A. Company Information, Head Office, Market Area and Industry Position

Table 33. Sanofi S.A. Company Profile and Main Business

Table 34. Sanofi S.A. Human Pain Management Drug Models, Specifications and Application

Table 35. Sanofi S.A. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 36. Sanofi S.A. Recent Developments

Table 37. Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position

Table 38. Boehringer Ingelheim International GmbH Company Profile and Main Business

Table 39. Boehringer Ingelheim International GmbH Human Pain Management Drug Models, Specifications and Application

Table 40. Boehringer Ingelheim International GmbH Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 41. Boehringer Ingelheim International GmbH Recent Developments

Table 42. Pfizer Inc. Company Information, Head Office, Market Area and Industry Position

Table 43. Pfizer Inc. Company Profile and Main Business

Table 44. Pfizer Inc. Human Pain Management Drug Models, Specifications and Application

Table 45. Pfizer Inc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 46. Pfizer Inc. Recent Developments

Table 47. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Information, Head Office, Market Area and Industry Position

Table 48. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Profile and Main Business

Table 49. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Models, Specifications and Application

Table 50. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 51. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Developments

Table 52. GSK plc. Company Information, Head Office, Market Area and Industry Position

Table 53. GSK plc. Company Profile and Main Business

Table 54. GSK plc. Human Pain Management Drug Models, Specifications and Application

Table 55. GSK plc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 56. GSK plc. Recent Developments

Table 57. Abbott Laboratories, Inc. Company Information, Head Office, Market Area and Industry Position

Table 58. Abbott Laboratories, Inc. Company Profile and Main Business

Table 59. Abbott Laboratories, Inc. Human Pain Management Drug Models, Specifications and Application

Table 60. Abbott Laboratories, Inc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 61. Abbott Laboratories, Inc. Recent Developments

Table 62. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 63. Novartis AG Company Profile and Main Business

Table 64. Novartis AG Human Pain Management Drug Models, Specifications and Application

Table 65. Novartis AG Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 66. Novartis AG Recent Developments

Table 67. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Information, Head Office, Market Area and Industry Position

Table 68. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Profile and Main Business

Table 69. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Models, Specifications and Application

Table 70. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 71. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Developments

Table 72. Sun Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position

Table 73. Sun Pharmaceutical Industries Ltd. Company Profile and Main Business

Table 74. Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Models, Specifications and Application

Table 75. Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 76. Sun Pharmaceutical Industries Ltd. Recent Developments

Table 77. Teva Pharmaceuticals Ltd. Company Information, Head Office, Market Area and Industry Position

Table 78. Teva Pharmaceuticals Ltd. Company Profile and Main Business

Table 79. Teva Pharmaceuticals Ltd. Human Pain Management Drug Models, Specifications and Application

Table 80. Teva Pharmaceuticals Ltd. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 81. Teva Pharmaceuticals Ltd. Recent Developments

Table 82. Mallinckrodt Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 83. Mallinckrodt Pharmaceuticals Company Profile and Main Business

Table 84. Mallinckrodt Pharmaceuticals Human Pain Management Drug Models, Specifications and Application

Table 85. Mallinckrodt Pharmaceuticals Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 86. Mallinckrodt Pharmaceuticals Recent Developments

Table 87. Endo Pharmaceuticals Inc. Company Information, Head Office, Market Area and Industry Position

Table 88. Endo Pharmaceuticals Inc. Company Profile and Main Business

Table 89. Endo Pharmaceuticals Inc. Human Pain Management Drug Models, Specifications and Application

Table 90. Endo Pharmaceuticals Inc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 91. Endo Pharmaceuticals Inc. Recent Developments

Table 92. Bayer AG Company Information, Head Office, Market Area and Industry Position

Table 93. Bayer AG Company Profile and Main Business

Table 94. Bayer AG Human Pain Management Drug Models, Specifications and Application

Table 95. Bayer AG Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 96. Bayer AG Recent Developments

Table 97. F. Hoffmann-La Roche Ltd. Company Information, Head Office, Market Area and Industry Position

Table 98. F. Hoffmann-La Roche Ltd. Company Profile and Main Business

Table 99. F. Hoffmann-La Roche Ltd. Human Pain Management Drug Models, Specifications and Application

Table 100. F. Hoffmann-La Roche Ltd. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 101. F. Hoffmann-La Roche Ltd. Recent Developments

Table 102. Procter & Gamble Company Information, Head Office, Market Area and Industry Position

Table 103. Procter & Gamble Company Profile and Main Business

Table 104. Procter & Gamble Human Pain Management Drug Models, Specifications and Application

Table 105. Procter & Gamble Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 106. Procter & Gamble Recent Developments

Table 107. AstraZeneca Company Information, Head Office, Market Area and Industry Position

Table 108. AstraZeneca Company Profile and Main Business

Table 109. AstraZeneca Human Pain Management Drug Models, Specifications and Application

Table 110. AstraZeneca Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 111. AstraZeneca Recent Developments

Table 112. Cardinal Health Company Information, Head Office, Market Area and Industry Position

Table 113. Cardinal Health Company Profile and Main Business

Table 114. Cardinal Health Human Pain Management Drug Models, Specifications and Application

Table 115. Cardinal Health Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 116. Cardinal Health Recent Developments

Table 117. Perrigo Company Plc. Company Information, Head Office, Market Area and Industry Position

Table 118. Perrigo Company Plc. Company Profile and Main Business

Table 119. Perrigo Company Plc. Human Pain Management Drug Models, Specifications and Application

Table 120. Perrigo Company Plc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 121. Perrigo Company Plc. Recent Developments

Table 122. Bausch Health Companies Inc. Company Information, Head Office, Market Area and Industry Position

Table 123. Bausch Health Companies Inc. Company Profile and Main Business

Table 124. Bausch Health Companies Inc. Human Pain Management Drug Models, Specifications and Application

Table 125. Bausch Health Companies Inc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 126. Bausch Health Companies Inc. Recent Developments

Table 127. Viatris Company Information, Head Office, Market Area and Industry Position

Table 128. Viatris Company Profile and Main Business

Table 129. Viatris Human Pain Management Drug Models, Specifications and Application

Table 130. Viatris Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 131. Viatris Recent Developments

Table 132. Amneal Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 133. Amneal Pharmaceuticals Company Profile and Main Business

Table 134. Amneal Pharmaceuticals Human Pain Management Drug Models, Specifications and Application

Table 135. Amneal Pharmaceuticals Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 136. Amneal Pharmaceuticals Recent Developments

Table 137. Purdue Pharmaceuticals L.P. Company Information, Head Office, Market Area and Industry Position

Table 138. Purdue Pharmaceuticals L.P. Company Profile and Main Business

Table 139. Purdue Pharmaceuticals L.P. Human Pain Management Drug Models, Specifications and Application

Table 140. Purdue Pharmaceuticals L.P. Human Pain Management Drug Revenue and Gross Margin, 2018-2023

Table 141. Purdue Pharmaceuticals L.P. Recent Developments

List of Figure

Figure 1. Human Pain Management Drug Picture

Figure 2. Global Human Pain Management Drug Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Human Pain Management Drug Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Human Pain Management Drug Market Share of Global

Figure 5. Global Human Pain Management Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Human Pain Management Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Human Pain Management Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Human Pain Management Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Human Pain Management Drug Industry Chain

Figure 10. OTC

Figure 11. Rx

Figure 12. By Type, Global Human Pain Management Drug Revenue, 2018-2029, US$ Million

Figure 13. By Type, Global Human Pain Management Drug Revenue Market Share, 2018-2029

Figure 14. Hospital

Figure 15. Retail Pharmacy

Figure 16. Other

Figure 17. By Application, Global Human Pain Management Drug Revenue, 2018-2029, US$ Million

Figure 18. By Application, Global Human Pain Management Drug Revenue Market Share, 2018-2029

Figure 19. By Region, Global Human Pain Management Drug Revenue Market Share, 2018-2029

Figure 20. North America Human Pain Management Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 21. By Country, North America Human Pain Management Drug Revenue Market Share, 2018-2023

Figure 22. Europe Human Pain Management Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 23. By Country, Europe Human Pain Management Drug Revenue Market Share, 2018-2023

Figure 24. Asia Pacific Human Pain Management Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 25. By Country/Region, Asia Pacific Human Pain Management Drug Revenue Market Share, 2018-2023

Figure 26. South America Human Pain Management Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 27. By Country, South America Human Pain Management Drug Revenue Market Share, 2018-2023

Figure 28. Middle East & Africa Human Pain Management Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 29. U.S. Human Pain Management Drug Revenue, 2018-2029, (US$ Million)

Figure 30. By Company, U.S. Human Pain Management Drug Market Share, 2018-2023

Figure 31. By Type, U.S. Human Pain Management Drug Revenue Market Share, 2022 VS 2029

Figure 32. By Application, U.S. Human Pain Management Drug Revenue Market Share, 2022 VS 2029

Figure 33. Europe Human Pain Management Drug Revenue, 2018-2029, (US$ Million)

Figure 34. By Company, Europe Human Pain Management Drug Market Share, 2018-2023

Figure 35. By Type, Europe Human Pain Management Drug Revenue Market Share, 2022 VS 2029

Figure 36. By Application, Europe Human Pain Management Drug Revenue Market Share, 2022 VS 2029

Figure 37. China Human Pain Management Drug Revenue, 2018-2029, (US$ Million)

Figure 38. By Company, China Human Pain Management Drug Market Share, 2018-2023

Figure 39. By Type, China Human Pain Management Drug Revenue Market Share, 2022 VS 2029

Figure 40. By Application, China Human Pain Management Drug Revenue Market Share, 2022 VS 2029

Figure 41. Japan Human Pain Management Drug Revenue, 2018-2029, (US$ Million)

Figure 42. By Company, Japan Human Pain Management Drug Market Share, 2018-2023

Figure 43. By Type, Japan Human Pain Management Drug Revenue Market Share, 2022 VS 2029

Figure 44. By Application, Japan Human Pain Management Drug Revenue Market Share, 2022 VS 2029

Figure 45. South Korea Human Pain Management Drug Revenue, 2018-2029, (US$ Million)

Figure 46. By Company, South Korea Human Pain Management Drug Market Share, 2018-2023

Figure 47. By Type, South Korea Human Pain Management Drug Revenue Market Share, 2022 VS 2029

Figure 48. By Application, South Korea Human Pain Management Drug Revenue Market Share, 2022 VS 2029

Figure 49. Southeast Asia Human Pain Management Drug Revenue, 2018-2029, (US$ Million)

Figure 50. By Company, Southeast Asia Human Pain Management Drug Market Share, 2018-2023

Figure 51. By Type, Southeast Asia Human Pain Management Drug Revenue Market Share, 2022 VS 2029

Figure 52. By Application, Southeast Asia Human Pain Management Drug Revenue Market Share, 2022 VS 2029

Figure 53. India Human Pain Management Drug Revenue, 2018-2029, (US$ Million)

Figure 54. By Company, India Human Pain Management Drug Market Share, 2018-2023

Figure 55. By Type, India Human Pain Management Drug Revenue Market Share, 2022 VS 2029

Figure 56. By Application, India Human Pain Management Drug Revenue Market Share, 2022 VS 2029

Figure 57. Middle East & Asia Human Pain Management Drug Revenue, 2018-2029, (US$ Million)

Figure 58. By Company, Middle East & Asia Human Pain Management Drug Market Share, 2018-2023

Figure 59. By Type, Middle East & Asia Human Pain Management Drug Revenue Market Share, 2022 VS 2029

Figure 60. By Application, Middle East & Asia Human Pain Management Drug Revenue Market Share, 2022 VS 2029

Figure 61. Research Methodology

Figure 62. Breakdown of Primary Interviews

Figure 63. Bottom-up Approaches

Figure 64. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)